Nuclear factor‐κB and the hepatic inflammation‐fibrosis‐cancer axis†
Citations Over TimeTop 10% of 2007 papers
Abstract
Nuclear factor-kappaB (NF-kappaB) is a transcriptional regulator of genes involved in immunity, inflammatory response, cell fate, and function. Recent attention has focused on the pathophysiological role of NF-kappaB in the diseased liver. In vivo studies using rodent models of liver disease and cell-targeted perturbation of NF-kappaB activity have revealed complex and multicellular functions in hepatic inflammation, fibrosis, and the development of hepatocellular carcinoma - a process we have termed the "inflammation-fibrosis-cancer axis". This review summarizes the current state of knowledge and provides insight into the vast complexity of the hepatic NF-kappaB signaling system, which should provide a rich source of new therapeutic targets.
Related Papers
- → Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets(2018)197 cited
- → A Selective PPARγ Modulator Reduces Hepatic Fibrosis(2020)6 cited
- → Non-Invasively Distinguishing Progress of Liver Fibrosis by Visualizing Hepatic Platelet Derived Growth Factor Receptor-Beta Expression with an MRI Modality in Mice(2020)1 cited
- Effectiveness of saponins from Panax notoginseng against hepatic fibrosis(2007)
- → Research progress on the relationship between transforming growth factor-β1 and hepatic fibrosis(2017)